Buckbinder L, Crawford DT, Qi H, Ke HZ, Olson LM, Long KR, et al., Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc. Natl. Acad. Sci. U. S. A. 25 , 10619-24, (2007)
Han S, Mistry A, Chang JS, Cunningham D, et al., Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design. J. Biol. Chem. 19 , 13193-201, (2009)
Walker DP, Bi FC, Kalgutkar AS, Bauman JN, Zhao SX, et al., Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation. Bioorg. Med. Chem. Lett. 23 , 6071-77, (2008)
安全信息
GHS Symbol
Precautionary statements
P301+P310
P305+P351+P338
Signal word
Danger
Hazard statements
H319 Causes serious eye irritation 严重刺激眼睛
H301 Toxic if swallowed 吞食有毒
WGK Germany3
Safety Statements
S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);